High-fat diet enhances visceral advanced glycation end products, nuclear O-Glc-Nac modification, p38 mitogen-activated protein kinase activation and apoptosis

Diabetes, Obesity and Metabolism

Volumn 7, Issue 4, 2005, Pages 448-454

  Li, S Y ^a   Liu, Y ^a   Sigmon, V K ^a   McCort, A ^a   Ren, Jun ^a  

^a UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

Author keywords

Advanced glycation end products; Apoptosis; High fat diet; O Glc NAcylation; Obesity

Indexed keywords

ACETYLGLUCOSAMINIDASE; ADVANCED GLYCATION END PRODUCT; CASPASE 3; DNA FRAGMENT; EXTRACHROMOSOMAL DNA; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CELL NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE METABOLISM; HEART RATE; KIDNEY METABOLISM; LIPID DIET; LIVER METABOLISM; LOW CALORY DIET; MALE; NONHUMAN; OBESITY; PATHOGENESIS; PROTEIN MODIFICATION; RAT; TISSUE INJURY; VISCERA; WEIGHT GAIN; WESTERN BLOTTING;

EID: 21444448717     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2004.00387.x     Document Type: Article

References (25)

1. Lichtenstein AH, Kennedy E, Barrier P et al. Dietary fat consumption and health. Nutr Rev 1998; 56: S3-S19.
2. Sanders TA. High- versus low-fat diets in human diseases. Curr Opin Clin Nutr Metab Care 2003; 6: 151-155.
3. Unger RH, Orci L. Lipotoxic diseases of nonadipose tissues in obesity. Int J Obes Relat Metab Disord 2000; 24 (Suppl. 4): S28-S32 (Review).
4. Unger RH, Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 2001; 15: 312-321 (Review).
5. Vosseller K, Sakabe K, Wells L, Hart GW. Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification. Curr Opin Chem Biol 2002; 6: 851-857.
6. Bidasee KR, Nallani K, Yu Y et al. Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. Diabetes 2003; 52: 1825-1836.
7. Clark RJ, McDonough PM, Swanson E et al. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J Biol Chem 2003; 278: 44230-44237.
8. Dukic-Stefanovic S, Gasic-Milenkovic J, Deuther-Conrad W, Munch G. Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs). J Neurochem 2003; 87: 44-55.
9. Pirola L, Johnston AM, Van Obberghen E. Modulators of insulin action and their role in insulin resistance. Int J Obes Relat Metab Disord 2003; 27 (Suppl. 3): S61-S64.
10. Cobellis G, Meccariello R, Minucci S, Palmiero C, Pierantoni R, Fasano S. Cytoplasmic versus nuclear localization of Fos-related proteins in the frog, Rana esculenta, testis: in vivo and direct in vitro effect of a gonadotropin-releasing hormone agonist. Biol Reprod 2003; 68: 954-960.
11. Horiuchi S, Araki N, Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure. J Biol Chem 1991; 266: 7329-7332.
12. Yanagisawa K, Makita Z, Shiroshita K et al. Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients. Metabolism 1998; 47: 1348-1353.
13. Li SY, Gomelski M, Duan J et al. Overexpression of aldehyde dehydrogenase-2 transgene attenuates acetaldehyde-induced apoptosis in human umbilical vein endothelial cells: role of ERK and p38 MAP kinase. J Biol Chem 2004; 279: 11244-11252.
14. Ren J, Duan J, Hintz KK, Ren BH. High glucose induces cardiac insulin-like growth factor I resistance in ventricular myocytes: role of Akt and ERK activation. Cardiovasc Res 2003; 57: 738-748.
15. Comer FI, Hart GW. O-glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and O-phosphate. J Biol Chem 2000; 275: 29179-29182.
16. Hart GW, Kreppel LK, Comer FI et al. O-GlcNAcylation of key nuclear and cytoskeletal proteins: reciprocity with O-phosphorylation and putative roles in protein multimerization. Glycobiology 1996; 6: 711-716.
17. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995; 46: 223-234.
18. Yan SF, Ramasamy R, Naka Y, Schmidt AM. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 2003; 93: 1159-1169.
19. Archer WR, Lamarche B, St-Pierre AC et al. High carbohydrate and high monounsaturated fatty acid diets similarly affect LDL electrophoretic characteristics in men who are losing weight. J Nutr 2003; 133: 3124-3129.
20. Fried SK, Rao SP. Sugars, hypertriglyceridemia, and cardiovascular disease. Am J Clin Nutr 2003; 78: 873S-880S.
21. Ren J, Sowers JR, Walsh MF, Brown RA. Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats. Am J Physiol Heart Circ Physiol 2003; 279: H1708-H1714.
22. Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJ. Development of hypertension in a rat model of diet-induced obesity. Hypertension 2000; 35: 1009-1015.
23. Dobrian AD, Davies MJ, Schriver SD, Lauterio TJ, Prewitt RL. Oxidative stress in a rat model of obesity-induced hypertension. Hypertension 2001; 37: 554-560.
24. Contreras RJ, King S. High fat/sucrose feeding attenuates the hypertension of spontaneously hypertensive rats. Physiol Behav 1989; 46: 285-291.
25. Contreras RJ, Williams VL. Dietary obesity and weight cycling: effects on blood pressure and heart rate in rats. Am J Physiol 1989; 256: R1209-R1219.